Cholangiocarcinoma

The Pharmacy Times® Cholangiocarcinoma Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of cholangiocarcinoma.

Latest News

Laptop displaying FDA logo -- Image credit: monticellllo | stock.adobe.com
FDA Grants PLT012 Orphan Drug Designation for Liver, Intrahepatic Bile Duct Cancer

December 11th 2024

PLT012 demonstrates its potential against multiple tumors with unmet medical needs.

Biliary tract cancer -- Image credit: Thipphaphone | stock.adobe.com
Intravenous Injections of Zanidatamab-Hrii Receives FDA Accelerated Approval for IHC+ BTC

November 21st 2024

3d illustration proteins with lymphocytes t cells or cancer cells | Image Credit: Design Cells - stock.adobe.com
Durvalumab With Chemotherapy Shows Long-Term Overall Survival at 3 Years

April 18th 2024

Medical conference panel
Pharmacists Can Help Address Treatment Challenges for Patients With Cholangiocarcinoma

December 19th 2023

Chalk drawing of human liver with medical term. Concept of learning medicine.
New FGFR Inhibition Therapies Show Promise in Intrahepatic Cholangiocarcinoma

June 4th 2023